Changing pharma dynamics & the IT-Pharmacy
Tue, 7/07/09 – 16:59 | 2 Comments

Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …

Read the full story »
News

Alensa’s own news as well as the latest insights, opinions and gossip from all corners of the generics industry.

formulations

Information about the latest generics coming to market as well as our own product launches and products under development.

direct compression

Direct compression products could be a major contributor to the generics industry lowering the cost of medicines even further. Find out all about it here.

pellets

Pellets are quickly becoming a competitive segment of the generics industry. Learn about all the latest producers and innovations here.

api

The cornerstone of generics has never been more exciting than now, with companies all over the world rushing to successfully launch the latest molecules. Follow the latest API action here.

Home » News

Adolf Merckle, owner of Ratiopharm, commits suicide

Submitted by admin on Tuesday, 6 January 2009No Comment

We were shocked today to read that the owner of both Ratiopharm, one of Europe’s largest generics companies and Phoenix PharmaHandel, Europe’s 2nd largest drug distributor, has committed suicide as a result of having lost billions of euros on the stock markets. Despite his great fortune, the losses on his recent bets in VW shares proved too great to salvage and led to this event.

Mr. Merckle’s success at developing the generics market can only be admired, helping to lower the cost of medicines for millions of people and increasing awareness about generics in general.  Our condolences go out to the Merckle family and the employees of Ratiopharm and Phoenix PharmaHandel.

Leave a comment!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.